Bfsg LLC Makes New $63,000 Investment in Bausch Health Companies Inc. (NYSE:BHC)

Bfsg LLC bought a new position in shares of Bausch Health Companies Inc. (NYSE:BHC) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 7,807 shares of the company’s stock, valued at approximately $63,000.

Several other institutional investors have also recently made changes to their positions in BHC. Ausdal Financial Partners Inc. bought a new stake in Bausch Health Companies during the third quarter valued at $86,000. Jump Financial LLC purchased a new position in shares of Bausch Health Companies during the third quarter worth about $92,000. Mitsubishi UFJ Trust & Banking Corp purchased a new position in shares of Bausch Health Companies during the third quarter worth about $103,000. Park Avenue Securities LLC purchased a new position in shares of Bausch Health Companies during the third quarter worth about $169,000. Finally, Pathstone Family Office LLC purchased a new position in shares of Bausch Health Companies during the third quarter worth about $169,000. Hedge funds and other institutional investors own 78.65% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently commented on BHC. Jefferies Financial Group cut their price objective on Bausch Health Companies from $16.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, February 20th. StockNews.com raised Bausch Health Companies from a “hold” rating to a “buy” rating in a report on Wednesday, February 7th. Finally, Royal Bank of Canada cut their price objective on Bausch Health Companies from $12.00 to $11.00 and set a “sector perform” rating for the company in a report on Tuesday.

Bausch Health Companies Stock Down 0.3 %

Shares of BHC opened at $8.59 on Friday. The stock has a 50 day simple moving average of $9.30 and a two-hundred day simple moving average of $8.16. Bausch Health Companies Inc. has a 1 year low of $5.57 and a 1 year high of $11.46.

Bausch Health Companies (NYSE:BHC) last released its quarterly earnings data on Thursday, February 22nd. The company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.01 by $0.14. The firm had revenue of $2.41 billion during the quarter, compared to analyst estimates of $2.29 billion. Bausch Health Companies had a positive return on equity of 5,147.48% and a negative net margin of 6.76%. The business’s quarterly revenue was up 9.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.02 earnings per share. On average, equities research analysts forecast that Bausch Health Companies Inc. will post 3.95 EPS for the current fiscal year.

Bausch Health Companies Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.